Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q2 2025 · 10-Q
Revenue$48.86M$48.86M−0.6% vs Q2 2024 Net Income$3.19M$3.19MN/M vs Q2 2024 EPS Diluted$0.10$0.10N/M vs Q2 2024 Operating Income$10,765,000+72.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$5,277,000−29.1% Margins · derivedOperating margin22.0%+9.4 pt vs Q2 2024
Net margin6.5%+20.9 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 8, 2025 · 39 d after period end